Zagazig University

• NCT07834398

  Phase 3, Completed, 150 people, 22 Sept 2026

• NCT07820111

  Phase 3, Completed, 159 people, 15 Sept 2026

• Comparative Study of Allopurinol and Febuxostat Effects in Hyperuricemia and Chronic Kidney Disease Patients Using Serum Asymmetric Dimethyl Arginine as an Endothelial Dysfunction Marker.

  Collaborator, Status unknown, 150 people, 30 Jul 2026

• NCT07330375

  Phase 3, Not yet recruiting, 50 people, 9 Jan 2026

• NCT06946212

  Phase 4, Completed, 34 people, 27 Apr 2025

• NCT06720220

  Phase 3, Completed, 56 people, 6 Dec 2024

• NCT06721247

  Phase 2/3, Active, not recruiting, 166 people, 6 Dec 2024

• NCT06561672

  Early phase 1, Status unknown, 102 people, 20 Aug 2024

• NCT06170463

  Phase 1, Completed, 210 people, 14 Dec 2023

• NCT05990686

  Phase 4, Completed, 102 people, 14 Aug 2023

• NCT05813249

  Phase 4, Completed, 180 people, 14 Apr 2023

• NCT05708625

  Phase 3, Status unknown, 136 people, 1 Feb 2023

• NCT05427474

  Phase 3, Status unknown, 90 people, 22 Jun 2022

• NCT05315128

  Phase 2, Completed, 60 people, 7 Apr 2022

• NCT05314127

  Phase 2, Status unknown, 80 people, 6 Apr 2022

• NCT05303311

  Phase 4, Completed, 46 people, 31 Mar 2022

• NCT05203562

  Phase 2/3, Status unknown, 200 people, 24 Jan 2022

• NCT05198141

  Phase 4, Completed, 60 people, 20 Jan 2022

• NCT04816162

  Phase 4, Completed, 120 people, 25 Mar 2021

• NCT04750837

  Phase 2, Completed, 72 people, 11 Feb 2021

Sources: trialsearch.who.int